Abstract
The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Current Drug Therapy
Title: Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine
Volume: 2 Issue: 2
Author(s): Joachim F. Wernicke, Smriti Iyengar and M. Dolores Ferrer-Garcia
Affiliation:
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Abstract: The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Export Options
About this article
Cite this article as:
Wernicke F. Joachim, Iyengar Smriti and Dolores Ferrer-Garcia M., Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine, Current Drug Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157488507780619086
DOI https://dx.doi.org/10.2174/157488507780619086 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Subject Index to Volume 2
Current Vascular Pharmacology A Yeast Extract High in Bioactive Peptides has a Blood-Pressure Lowering Effect in Hypertensive Model
Current Medicinal Chemistry Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents Catheter-directed Thrombolysis <i>versus</i> Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis
Current Cardiology Reviews Addiction Liability of Pharmacotherapeutic Interventions in Obesity
Current Pharmaceutical Design Neurological Aspects of Medical Use of Cannabidiol
CNS & Neurological Disorders - Drug Targets Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease
Current Stem Cell Research & Therapy Statin Therapy
Current Pharmaceutical Design Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase
Central Nervous System Agents in Medicinal Chemistry Prevention and treatment of atherosclerosis with flaxseed -derived compound secoisolariciresinol diglucoside
Current Pharmaceutical Design Biosafety of Adenoviral Vectors
Current Gene Therapy Role of Central and Peripheral Chemoreceptors in Vasopressin Secretion Control
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Agents for COVID-19: an Overview
Current Drug Therapy Editorial [Hot topic: Controversies in Hypertension Treatment (Guest Editors: Maciej Banach, Sverre E. Kjeldsen and Krzysztof Narkiewicz)]
Current Vascular Pharmacology Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Intravenous Immunoglobulin as a Potential Therapy for Refractory Urticaria - A Review
Inflammation & Allergy - Drug Targets (Discontinued) Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management
Current Pharmaceutical Design Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Current Drug Metabolism